James A. de Lemos, MD, FACC

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Glaxo Smith Kline(SIGNIFICANT), LianbIo(SIGNIFICANT), Cytokinetics(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Roche Diagnostics(SIGNIFICANT), Abbott Diagnostics(SIGNIFICANT) OTHER FINANCIAL BENEFIT: Beckman Coulter(SIGNIFICANT), Amgen(MODEST)

View Full Disclosure